Abstract:BACKGROUND:Bone marrow mesenchymal stem cells(BMSCs) have an enormous potential on myocardium-injured diseases via cardiomyogenesis,however,an ideal inducing method has not been found at present. OBJECTIVE:To investigate the potential of rat microvascular endothelial cells(mECs) on inducing BMSCs differentiation into cardiomyocytes,and to analyze the feasibility of transplantation. DESIGN,TIME AND SETTING:An observational experiment based on cells and animals was conducted at the Chongqing Key Laboratory of Neurology between July 2008 and February 2009. MATERIALS:A total of 16 clear healthy male Sprague Dawley rats aged 2-3 months were obtained from the Experimental Animal Center,Chongqing Medical University. METHODS:Transwell cabin of 0.4 μm bore was placed in culture plate well to construct double-cabin culture system. BMSCs and mECs were respectively isolated and cultured from 1 Sprague Dawley rat using Ficoll density gradient + adherence screening method and explant method. mECs were well cultured and reached 50% confluency. The medium was changed every 3 days. Following collection and filtration,the conditioned medium was obtained. In vitro experiment was divided into direct contact group(Ⅰ) ,bi-chamber coculture group(Ⅱ) ,conditioned medium group(Ⅲ) and medium control group(Ⅳ) ,and myocardial induction effect was observed in these conditions. A total of 15 healthy Sprague Dawley rats were committed to coronary ligation for myocardial infarction models and divided into cell implantation group(n=8) and model control group(n=6) . 1 week following model induction,BMSCs(109/L) processed with mECs for 5 days and equivalent DMEM(1 mL) were injected through tail veils,respectively in the cell implantation group and model control group,and then observed for 4 weeks. MAIN OUTCOME MEASURES:Cardiac markers as TnI and α-actin expression were tested using immunofluorescent staining in vitro. Implantation safety and feasibility were evaluated by electrocardiogram,fluorescent microscope and hematoxylin-eosin staining. RESULTS:Partial BMSCs in groupⅠ,Ⅱ and Ⅲ processed morphologic changes with TnI and α-actin positively expressed after induction. Cytoplasm emitted green(or red) under the fluoroscope. Induction rate in group Ⅰand groupⅡ respectively was similar(P > 0.05) ,and significantly greater than that in group Ⅲ and group Ⅳ(P <0.05) . Cells did not differentiate into cardiomyocytes in the group Ⅳ. All experiment animals lived well with no death or malignant arrhythmia following cell transplantation. Frozen sections of the heart showed a few blue-stained cells under the fluoroscope in the cell transplantation group 4 weeks later. This indicated that stem cells were successfully homing. Using hematoxylin-eosin staining,homing cells were distributed over the infarct zone,with the presence of single or mass. In the model control group,no blue-stained cells were determined. CONCLUSION:mECs can induce BMSCs differentiation into cardiac-like myocytes through paracrine mechanisms. Implantation of BMSCs pretreated with mECs into rats is safe,and can successfully homing to the rat infarct zone or surrounding the infarct zone.

Improvement of Heart Function After Transplantation of Encapsulated Stem Cells Induced with miR-1/Myocd in Myocardial Infarction Model of Rat

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

Differentiation of Mesenchymal Stem Cells Into Cardiac-like Cells by Co-induction of Lentiviruses Containing Mir-1 and Myocd in Chitosan Collagen Hydrogel Scaffold

Optimal Temporal Delivery of Bone Marrow Mesenchymal Stem Cells in Rats with Myocardial Infarction.

Bone Marrow Mesenchymal Stem Cells Induce Angiogenesis and Attenuate the Remodeling of Diabetic Cardiomyopathy

Transplantation of Mesenchymal Stem Cells from Human Bone Marrow Improves Damaged Heart Function in Rats.

Significant Improvement of Heart Function by Cotransplantation of Human Mesenchymal Stem Cells and Fetal Cardiomyocytes in Postinfarcted Pigs.

Transplantation of Mesenchymal Stem Cells Within A Poly(Lactide-Co-Epsilon-Caprolactone) Scaffold Improves Cardiac Function in A Rat Myocardial Infarction Model

Abstract P1103: A Combinatorial Stem Cell Therapy Using HiPSC-derived Cardiomyocytes And HiPSC-derived Mesenchymal Stem Cells For Cardiac Regeneration

Mechanism of Heart Function Improvement after Myocardial Transplantation of Bone Marrow Mesenchymal Stem Cells of Myocardial Infarction

Overexpression of MicroRNA-1 Improves the Efficacy of Mesenchymal Stem Cell Transplantation after Myocardial Infarction.

The Prostecdtive Efficacy of Mesechymal Stem Cells Transplantion on InfarctionInduced Heart Failure of Rats

Effect of Mesenchymal Stem Cell Transplantation and Differentiation in Infracted Myocardium on Infarction-Induced Heart Failure in Rats

Overexpression of Csx/Nkx2.5 and GATA-4 Enhances the Efficacy of Mesenchymal Stem Cell Transplantation after Myocardial Infarction

Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction

Role Of Microvascular Endothelial Cells On Inducing Bone Marrow Mesenchymal Stem Cells Differentiation Into Cardiomyocytes And Implantation Feasibility

Combinatorial Treatment of Acute Myocardial Infarction Using Stem Cells and Their Derived Exosomes Resulted in Improved Heart Performance

Intravenous Transplantation of Mesenchymal Stem Cells Improves Cardiac Performance after Acute Myocardial Ischemia in Female Rats

Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction.